quinazolines has been researched along with coumarin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grainger, DJ; Hesketh, TR; Metcalfe, JC; Weissberg, PL | 1 |
Aonuma, S; Nagao, M; Nakayasu, M; Shima, H; Sugimura, T | 1 |
Chang, FR; Chen, CY; Khalil, AT; Lee, YH; Liaw, CC; Ramesh, P; Wu, YC; Yuan, SS | 1 |
Cao, S; Gao, H; Jiang, X; Pang, Z; Xi, Z; Yang, Z; Zhang, S | 1 |
4 other study(ies) available for quinazolines and coumarin
Article | Year |
---|---|
Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells.
Topics: Acetamides; Animals; Cell Division; Cells, Cultured; Coumarins; DNA Replication; Endothelium, Vascular; Fibroblasts; Hematinics; Humans; Kinetics; Muscle, Smooth, Vascular; Quinazolines; Quinazolinones; Rats; Thymidine | 1992 |
Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide.
Topics: Benzamides; Blotting, Southern; Cell Differentiation; Cell Line; Coumarins; Dimethyl Sulfoxide; Gene Amplification; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Nucleic Acid Hybridization; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; Quinazolines; Quinazolinones; RNA, Neoplasm | 1989 |
Chemical constituents from the Hydrangea chinensis.
Topics: Coumarins; Hydrangea; Plant Extracts; Plant Leaves; Plant Roots; Quinazolines | 2003 |
Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Coumarins; Endocytosis; Fluorescent Antibody Technique; Glioma; Humans; Imaging, Three-Dimensional; In Situ Nick-End Labeling; Lapatinib; Lipoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Nanoparticles; Osteonectin; Quinazolines; Receptor, ErbB-2; Subcellular Fractions; Xenograft Model Antitumor Assays | 2012 |